JPRN-UMIN000012813
Completed
未知
Phase II trial as new adjuvant chemotherapy regimen for capecitabine in stage II and III colorectal cancer. - Phase II trial as new adjuvant chemotherapy regimen for capecitabine
Tsukasa Hotta0 sites25 target enrollmentJanuary 20, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- StageII(high risk) and stageIIIa resectable colorectal cancer
- Sponsor
- Tsukasa Hotta
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Pregnant female 2\.It may be pregnant state female 3\.Past history of malignant disease 4\.There is uncontrolled cerebrovascular disease 5\.There was serious allergy for fluorouracl related drug 6\.There was allergy due to the lack of DPD 7\.There is uncontrorable infection disease 8\.It is difficult to intake oral food 9\.Judgementof study controlled doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma patientscholangiocarecinoma:Stage III and IV of the Japanese General Rules for Surgical and Pathological Studies on Cancer of the Biliary TractJPRN-UMIN000001754Hepato-biliary pancreatic surgery,Tohoku University Hospital40
Active, not recruiting
Not Applicable
Phase I/II-Studie zur neoadjuvanten Chemotherapie mit nicht-pegyliertem liposomalem Doxorubicin, Paclitaxel und Lapatinib bei Patientinnen mit HER2-überexprimierenden, primärem MammakarzinomeEUCTR2007-000924-42-DESana Klinikum Lichtenberg
Not yet recruiting
Not Applicable
Phase 2 clinical study of neoadjuvant chemotherapy for HER2-negative primary breast cancer patients using dose dense nab-paclitaxel followed by dose dense Epirubicin and cyclophosphamideHER2 negative primary breast cancerJPRN-UMIN000019787Dept of breast oncology50
Recruiting
Not Applicable
A phase II clinical trial of neoadjuvant chemoradiation therapy for pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000035232Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University50
Completed
Phase 2
Phase II trial of adjuvant chemotherapy with modified medication of S-1 for pancreatic cancerpancreatic cancerJPRN-UMIN000002791Kyoto University Hospital35